Cargando…

Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report

INTRODUCTION: Pulmonary sarcomatoid carcinoma (PSC) is an extremely rare biphasic tumor characterized by a mixture of malignant epithelial and mesenchymal cells. Owing to the rarity, as well as the lack of typical manifestations and imaging signs, the rate of misdiagnosis is high. Herein, we present...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Le, Zhang, Jing, Chen, Xing, Liang, Maoli, Li, Shuo, Zhou, Wei, Cao, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589231/
https://www.ncbi.nlm.nih.gov/pubmed/34766593
http://dx.doi.org/10.1097/MD.0000000000027813
_version_ 1784598655889571840
author Wang, Le
Zhang, Jing
Chen, Xing
Liang, Maoli
Li, Shuo
Zhou, Wei
Cao, Jie
author_facet Wang, Le
Zhang, Jing
Chen, Xing
Liang, Maoli
Li, Shuo
Zhou, Wei
Cao, Jie
author_sort Wang, Le
collection PubMed
description INTRODUCTION: Pulmonary sarcomatoid carcinoma (PSC) is an extremely rare biphasic tumor characterized by a mixture of malignant epithelial and mesenchymal cells. Owing to the rarity, as well as the lack of typical manifestations and imaging signs, the rate of misdiagnosis is high. Herein, we present a case of PSC misdiagnosed as pleural mesothelioma in a 59-year-old man. PATIENT CONCERNS: A 59-year-old man presented with recurrent coughing, fever, and chest pain. DIAGNOSIS: Chest computed tomography showed 2 large and dense masses involving the inferior lobes of right lung, along with slight irregular pleural thickening and a small amount of effusion. INTERVENTIONS: Chest computed tomography-guided tumor biopsy was performed. PSC was confirmed based on histopathology and immunohistochemistry. The patient refused treatment due to economic reasons. OUTCOMES: The patient developed adrenal, multiple lung and brain metastasis. The overall survival time was 11 months. CONCLUSIONS: PSC, despite its rarity, should be considered in the differential diagnosis of lung cancer. Besides, biopsy, histopathology, and specific immunohistochemical staining of larger tissue specimens can be contributing to the accurate diagnosis of PSC.
format Online
Article
Text
id pubmed-8589231
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-85892312021-11-15 Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report Wang, Le Zhang, Jing Chen, Xing Liang, Maoli Li, Shuo Zhou, Wei Cao, Jie Medicine (Baltimore) 6700 INTRODUCTION: Pulmonary sarcomatoid carcinoma (PSC) is an extremely rare biphasic tumor characterized by a mixture of malignant epithelial and mesenchymal cells. Owing to the rarity, as well as the lack of typical manifestations and imaging signs, the rate of misdiagnosis is high. Herein, we present a case of PSC misdiagnosed as pleural mesothelioma in a 59-year-old man. PATIENT CONCERNS: A 59-year-old man presented with recurrent coughing, fever, and chest pain. DIAGNOSIS: Chest computed tomography showed 2 large and dense masses involving the inferior lobes of right lung, along with slight irregular pleural thickening and a small amount of effusion. INTERVENTIONS: Chest computed tomography-guided tumor biopsy was performed. PSC was confirmed based on histopathology and immunohistochemistry. The patient refused treatment due to economic reasons. OUTCOMES: The patient developed adrenal, multiple lung and brain metastasis. The overall survival time was 11 months. CONCLUSIONS: PSC, despite its rarity, should be considered in the differential diagnosis of lung cancer. Besides, biopsy, histopathology, and specific immunohistochemical staining of larger tissue specimens can be contributing to the accurate diagnosis of PSC. Lippincott Williams & Wilkins 2021-11-12 /pmc/articles/PMC8589231/ /pubmed/34766593 http://dx.doi.org/10.1097/MD.0000000000027813 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 6700
Wang, Le
Zhang, Jing
Chen, Xing
Liang, Maoli
Li, Shuo
Zhou, Wei
Cao, Jie
Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report
title Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report
title_full Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report
title_fullStr Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report
title_full_unstemmed Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report
title_short Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: A case report
title_sort pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: a case report
topic 6700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589231/
https://www.ncbi.nlm.nih.gov/pubmed/34766593
http://dx.doi.org/10.1097/MD.0000000000027813
work_keys_str_mv AT wangle pulmonarysarcomatoidcarcinomamimickingpleuralmesotheliomaacasereport
AT zhangjing pulmonarysarcomatoidcarcinomamimickingpleuralmesotheliomaacasereport
AT chenxing pulmonarysarcomatoidcarcinomamimickingpleuralmesotheliomaacasereport
AT liangmaoli pulmonarysarcomatoidcarcinomamimickingpleuralmesotheliomaacasereport
AT lishuo pulmonarysarcomatoidcarcinomamimickingpleuralmesotheliomaacasereport
AT zhouwei pulmonarysarcomatoidcarcinomamimickingpleuralmesotheliomaacasereport
AT caojie pulmonarysarcomatoidcarcinomamimickingpleuralmesotheliomaacasereport